IDEAYA Biosciences, Inc.
IDYAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How IDEAYA Biosciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | 2026-03-31 | 241,508 | $8.05M | SEC filing |
| Vanguard Personalized Indexing Management, LLC | 2026-03-31 | 15,614 | $520K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 1,315,869 | Not shown | SEC filing |
| NATIONAL BANK OF CANADA /FI/ | 2026-03-31 | 24 | $799 | SEC filing |
| E Fund Management Co., Ltd. | 2026-03-31 | 10,897 | $363K | SEC filing |
| Cassaday & Co Wealth Management LLC | 2026-03-31 | 380 | $12.7K | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 7,992 | $266K | SEC filing |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 2026-03-31 | 122,064 | $4.07M | SEC filing |
| Ishara Investments LP | 2026-03-31 | 24,600 | $820K | SEC filing |
| Point72 Asset Management, L.P. | 2026-03-31 | 327,901 | $10.9M | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 2,229 | $74.3K | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 84,760 | $2.82M | SEC filing |
| KVP Capital Advisors, LP | 2026-03-31 | 79,700 | $2.66M | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 23,052 | $768K | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 6,710 | $224K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 292,106 | $9.19M | SEC filing |
| CVA Family Office, LLC | 2026-03-31 | 10 | $333 | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 228,980 | $7.63M | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 9,589 | $292K | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 115 | $3.83K | SEC filing |
- Each value is checked against IDEAYA Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at IDEAYA Biosciences, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among IDEAYA Biosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-05-16 · Hata Yujiro S: Larger than 61 of the 66 other insider sales of Common Stock on file. SEC filing
- 2024-05-15 · Hata Yujiro S: Larger than 62 of the 66 other insider sales of Common Stock on file. SEC filing
- 2024-05-15 · Hata Yujiro S: Larger than 60 of the 66 other insider sales of Common Stock on file. SEC filing
- 2024-05-14 · Hata Yujiro S: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
- 2024-02-08 · Hata Yujiro S: Larger than all 66 other insider sales of Common Stock on file. SEC filing
- 2024-01-16 · Hata Yujiro S: Larger than 64 of the 66 other insider sales of Common Stock on file. SEC filing
- 2023-12-15 · Hata Yujiro S: Larger than 65 of the 66 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-02 | Stein Jeffrey · Director | Common Stock | P — Open market or private purchase | +50,000 | 32.96 | SEC filing |
| 2024-05-29 | WHITE MICHAEL ANTHONY · Chief Scientific Officer | Common Stock | S — Open market or private sale | −851 | 36.78 | SEC filing |
| 2024-05-29 | WHITE MICHAEL ANTHONY · Chief Scientific Officer | Common Stock | S — Open market or private sale | −27,649 | 36.23 | SEC filing |
| 2024-05-16 | Hata Yujiro S · President and CEO | Common Stock | S — Open market or private sale | −30,084 | 41.73 | SEC filing |
| 2024-05-16 | Hata Yujiro S · President and CEO | Common Stock | S — Open market or private sale | −4,349 | 42.37 | SEC filing |
| 2024-05-15 | Hata Yujiro S · President and CEO | Common Stock | S — Open market or private sale | −503 | 44.12 | SEC filing |
| 2024-05-15 | Hata Yujiro S · President and CEO | Common Stock | S — Open market or private sale | −29,761 | 43.48 | SEC filing |
| 2024-05-15 | Hata Yujiro S · President and CEO | Common Stock | S — Open market or private sale | −53,592 | 42.57 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-16 | Hampton Malcolm Garret · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-16 | Morrison Scott W · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-16 | MACKEY CATHERINE J · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-16 | YARNO WENDY L · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-16 | ROSEN TERRY J · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-06-16 | Stein Jeffrey · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +20,000 | SEC filing |
| 2026-01-30 | Hata Yujiro S · President and CEO | Stock Option (right to buy) | A — Grant, award, or other acquisition | +600,000 | SEC filing |
| 2026-01-30 | Ruiz Briseno Andres · See Remarks | Stock Option (right to buy) | A — Grant, award, or other acquisition | +80,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.